Insider Transactions in Q4 2024 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,361
-1.33%
|
$126,469
$29.53 P/Share
|
|
Oct 23
2024
|
Jay S Stout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,740
-1.89%
|
$79,460
$29.53 P/Share
|
|
Oct 23
2024
|
Michael Geffner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,189
-2.31%
|
$92,481
$29.53 P/Share
|
|
Oct 16
2024
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,188
-0.43%
|
$89,264
$28.79 P/Share
|
|
Oct 16
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,095
-0.91%
|
$254,660
$28.79 P/Share
|
|
Oct 16
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,271
-0.97%
|
$91,588
$28.79 P/Share
|
|
Oct 16
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,860
-0.87%
|
$80,080
$28.79 P/Share
|
|
Oct 09
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,460
-0.44%
|
$129,340
$29.56 P/Share
|
|
Oct 09
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,162
-1.5%
|
$149,698
$29.56 P/Share
|